Clinical trial
GALLANT 5 Tesaglitazar Versus Metformin
NCT00214591
Study timeline
Study start (unknown)2004-08-01Date precision: month
Registry last updated2010-11-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus, Type 2unresolved
Interventions
GALIDADRUG
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
New YorkNew York, United States1Los AngelesCalifornia, United States1PhiladelphiaPennsylvania, United States1DallasTexas, United States1BaltimoreMaryland, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1San AntonioTexas, United States1MadridSpain1BarcelonaSpain1BirminghamAlabama, United States1CincinnatiOhio, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00214591 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.